Traders Buy Shares of WebMD Health Corp. (WBMD) on Weakness After Insider Selling
Traders purchased shares of WebMD Health Corp. (NASDAQ:WBMD) on weakness during trading on Monday following insider selling activity. $17.92 million flowed into the stock on the tick-up and $1.64 million flowed out of the stock on the tick-down, for a money net flow of $16.28 million into the stock. Of all stocks tracked, WebMD Health Corp. had the 31st highest net in-flow for the day. WebMD Health Corp. traded down ($0.11) for the day and closed at $53.70Specifically, Chairman Martin J. Wygod sold 89,843 shares of the business’s stock in a transaction on Monday, November 21st. The stock was sold at an average price of $53.94, for a total transaction of $4,846,131.42. Following the completion of the sale, the chairman now owns 156,591 shares in the company, valued at $8,446,518.54. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Douglas W. Wamsley sold 27,953 shares of the business’s stock in a transaction on Wednesday, November 23rd. The stock was sold at an average price of $53.79, for a total value of $1,503,591.87. Following the sale, the vice president now owns 44,072 shares of the company’s stock, valued at approximately $2,370,632.88. The disclosure for this sale can be found here. Insiders own 8.10% of the company’s stock.
A number of research firms have recently weighed in on WBMD. Leerink Swann restated a “buy” rating on shares of WebMD Health Corp. in a research report on Wednesday, September 28th. Zacks Investment Research upgraded WebMD Health Corp. from a “sell” rating to a “hold” rating in a research report on Tuesday, September 20th. Mizuho restated a “buy” rating and set a $63.00 target price (down previously from $68.00) on shares of WebMD Health Corp. in a research report on Monday, September 19th. Goldman Sachs Group Inc. reiterated a “neutral” rating and issued a $62.00 price objective on shares of WebMD Health Corp. in a report on Thursday, August 11th. Finally, Citigroup Inc. upped their price objective on WebMD Health Corp. from $62.00 to $64.00 and gave the company a “neutral” rating in a report on Tuesday, August 9th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and two have issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $64.29.
The firm has a market capitalization of $2.01 billion, a PE ratio of 29.93 and a beta of 0.34. The stock’s 50-day moving average price is $51.80 and its 200-day moving average price is $56.03.
WebMD Health Corp. (NASDAQ:WBMD) last issued its earnings results on Tuesday, November 1st. The company reported $0.47 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.40 by $0.07. The firm had revenue of $171.40 million for the quarter, compared to the consensus estimate of $169.96 million. WebMD Health Corp. had a return on equity of 35.64% and a net margin of 11.97%. The company’s revenue was up 12.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 EPS. Equities analysts predict that WebMD Health Corp. will post $1.91 EPS for the current year.
Several large investors have recently modified their holdings of WBMD. Old Mutual Global Investors UK Ltd. acquired a new stake in shares of WebMD Health Corp. during the second quarter worth $5,335,000. LS Investment Advisors LLC acquired a new stake in shares of WebMD Health Corp. during the second quarter worth $134,000. Copper Rock Capital Partners LLC acquired a new stake in shares of WebMD Health Corp. during the second quarter worth $18,126,000. Capital One National Association increased its stake in shares of WebMD Health Corp. by 67.1% in the second quarter. Capital One National Association now owns 42,453 shares of the company’s stock worth $2,467,000 after buying an additional 17,049 shares in the last quarter. Finally, Telemus Capital LLC acquired a new stake in shares of WebMD Health Corp. during the second quarter worth $639,000. 84.55% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: “Traders Buy Shares of WebMD Health Corp. (WBMD) on Weakness After Insider Selling” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this story can be accessed at https://www.thecerbatgem.com/2016/11/29/traders-buy-shares-of-webmd-health-corp-wbmd-on-weakness-after-insider-selling.html.
WebMD Health Corp. Company Profile
WebMD Health Corp. is a provider of health information services. The Company provides its services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications. The WebMD Health Network includes: www.WebMD.com, its primary public portal for consumers and related mobile-optimized sites and mobile apps; www.Medscape.com, its primary public portal for physicians and other healthcare professionals and related mobile services; and other sites through which, the Company provides its branded health and wellness content, tools and services.
Receive News & Stock Ratings for WebMD Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WebMD Health Corp. and related stocks with our FREE daily email newsletter.